Mounjaro contains tirzepatide , which targets two hormones (GLP-1 and GIP), providing additional benefits for both blood sugar control and weight loss, but its weight loss effectiveness is still being studied
Notably, there was a large variability after treatment for all three hormones
If the doubled dose was still below 2.5 mg, you have not exceeded the standard starting dose
For obesity therapeutics, Phase 3 trials are especially important because regulators want to see: Long-term weight loss sustainability Cardiovascular safety Real-world tolerability Effects on obesity-related conditions such as diabetes, sleep apnea, and osteoarthritis Retatrutides Phase 3 program, called TRIUMPH , includes multiple large-scale studies across different patient populations
How much does compounded semaglutide cost through FuturHealth